FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.
FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.
Complix is a biopharmaceutical company engaged in the discovery and development of Alphabodies™, a revolutionary class of biopharmaceuticals with exceptional properties. Alphabodies™ combine beneficial properties of small molecules with those of antibodies, and can address intracellular as well as extracellular disease targets that are undruggable by antibodies or small chemical drugs. Complix has developed a balanced pipeline of transformative protein therapeutics in oncology, autoimmunity/inflammation and viral diseases.
Complix is an early-stage biotech company developing therapeutic proteins for inflammation, auto-immune and infectious diseases.
The Alphabody™ is a protein scaffold based on a triple-α-helical coiled coil architecture. Alphabodies™ are extremely stable and highly engineerable. The coiled coil part is extendable, making it a truly scalable scaffold. The Alphabody™ technology allows the development of specific binders with high affinity against a wide range of biomolecules.
CRP Santé VIB